The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM & Proposed Changes to Option Scheme

3 Apr 2023 07:00

RNS Number : 0423V
Osirium Technologies PLC
03 April 2023
 

03 April 2023

 

Osirium Technologies plc

("Osirium", the "Group" or the "Company")

 

Posting of annual report and accounts, notice of AGM,

proposed amendments to share option plan and proposed grant of options

 

Posting of accounts and notice of AGM

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, announces that the Company's annual report and accounts for the year ended 31 December 2022, which incorporates notice of the Company's 2023 Annual General Meeting ("AGM") will shortly be posted to shareholders who have elected to receive a hard copy of them and will be available to download from the Company's website at www.osirium.com.

 

The AGM will be held at the Company's offices at Theale Court, 11-13 High Street, Theale, RG7 5AH at 11:00 a.m. on Tuesday, 9 May 2023.

 

Proposed amendments to share option scheme and grant of options

 

The AGM notice contains a resolution (the "Plan Resolution") to permit the Directors to make certain amendments to the Company's Enterprise Management Incentive (EMI) Share Option Plan 2020-2025 (the "Plan"), including, inter alia, the ability to set the exercise price of new options granted pursuant to the Plan equal to the market price of an ordinary share in the Company ("Ordinary Share") at the date of grant.

 

The Plan was put in place in 2020 with a primary goal of incentivising and retaining Directors and key employees of the Company to drive the Company's future growth and share value. The current Plan rules do not permit the grant of options with an exercise price of less than 35p per option, being a premium of over 2000% to the current mid-market price of an Ordinary Share. Accordingly, Osirium's remuneration committee has proposed amendments to the scheme to confer wider discretion on the Board to grant options over Ordinary Shares at no lesser amount than the market value of the Company's shares at the date of grant, and exercisable on conditions and at vesting periods which they regard as more aligned with the interests of the Company to provide meaningful and achievable incentives to the Company's directors and staff.

 

Furthermore, the existing options granted pursuant to the Plan have an exercise price of 35p and the Company has historic options outstanding granted pursuant to the Osirium Technologies plc Enterprise Management Incentive (EMI) Share Option Plan 2016, adopted at the time of the Company's IPO, which have exercise prices of between 41.67p and 187.2p per Ordinary Share. The Board does not consider that any of these options provide a meaningful incentive to option holders.

 

Subject to the passing of the Plan Resolution at the AGM and shortly following the conclusion of the AGM, it is anticipated that all existing holders of outstanding options over Ordinary Shares will be invited to surrender their current options and would be granted new options (the "New Options"), exercisable at the market price of an Ordinary Share at the time of grant, such number of options to be determined by Osirium's Remuneration Committee. It is anticipated that the New Options would be subject to a three-year vesting period, with the options vesting as to: one third on the first anniversary of grant; one third on the second anniversary of grant; and one third on the third anniversary of grant.

 

It is anticipated that the following number of options would be granted to Directors and PDMRs of the Company:

 

Director

No. of existing options currently held and to be surrendered

No. of New Options to be granted

Percentage of existing issued share capital of the Company represented by the New Options

David Guyatt (Chairman)

1,061,416

1,225,487

1.00%

Stuart McGregor (CEO)

218,500

2,450,974

2.00%

Rupert Hutton (CFO)

147,250

1,225,487

1.00%

Simon Lee (NED)

147,250

183,823

0.15%

Simon Hember (NED)

26,125

183,823

0.15%

Catherine Jamieson

(wife of David Guyatt)

180,000

612,743

0.50%

 

Full details of the proposed amendments to the Plan are set out in the explanatory notes to the notice of AGM. Should the Plan Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Plan or grant the New Options. A further announcement will be made on conclusion of the AGM.

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Will Ellis Hancock

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAEALLAEDKDEFA
Date   Source Headline
15th Oct 20207:00 amRNSContract win with leading healthcare provider
8th Oct 20207:00 amRNSCompetitive contract win with major UK Retailer
29th Sep 20207:00 amRNSInterim Results
21st Sep 20207:00 amRNSNotice of Results
16th Jun 202012:00 pmRNSResult of AGM
15th May 20207:00 amRNSFinal Results
8th Apr 20207:00 amRNSCOVID-19 Update and Contract Renewal
17th Mar 20207:00 amRNSContract win with major regional Ambulance Service
24th Feb 20203:46 pmRNSHolding(s) in Company
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
14th Jan 20207:00 amRNSTrading Update
11th Dec 20197:00 amRNSLaunch of Privileged Endpoint Manager solution
14th Nov 20195:25 pmRNSHolding(s) in Company
31st Oct 201910:48 amRNSTotal Voting Rights
30th Oct 201911:35 amRNSHolding(s) in Company
29th Oct 201912:09 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSResult of fundraise
21st Oct 20197:00 amRNSProposed fundraise
10th Oct 20197:00 amRNSNew customer and upsell contract wins
23rd Sep 20197:00 amRNSSubstantial contract win
18th Sep 20197:00 amRNSHalf Year Report
10th Sep 20191:27 pmRNSNotice of Results
14th Aug 20197:00 amRNSFirst contract win for Opus
7th Aug 20197:00 amRNSContract wins
8th Jul 20197:00 amRNSTrading update
13th Jun 201912:07 pmRNSResult of AGM
6th Jun 20197:00 amRNSContract win
4th Jun 20197:00 amRNSInfosecurity Europe 2019
29th May 20197:00 amRNSHolding(s) in Company
17th May 20197:00 amRNSContract Extension
8th May 20197:00 amRNSFinal Results
1st May 20197:00 amRNSLaunch of secure IT Process Automation solution
29th Apr 20197:00 amRNSNotice of Final Results
18th Apr 20194:05 pmRNSHolding(s) in Company
22nd Mar 20194:30 pmRNSHolding(s) in Company
27th Feb 20197:00 amRNSContract wins
12th Feb 20197:00 amRNSContract win
14th Jan 20197:00 amRNSTrading Update
9th Jan 20191:59 pmRNSHolding(s) in Company
8th Jan 20197:00 amRNSContract win with major Business Energy player
19th Dec 20187:00 amRNSContract win with Financial Services provider
5th Oct 20187:00 amRNSGrant of options and PDMR dealings
25th Sep 20187:00 amRNSInterim results
21st Sep 20187:00 amRNSContract win with UK Fashion and Homeware Retailer
19th Sep 20187:00 amRNSStrategic Technology Partnership with RazorSecure
6th Aug 20187:00 amRNSNotice of Interim Results
24th May 201811:31 amRNSResult of AGM
14th May 201810:39 amRNSHolding(s) in Company
24th Apr 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.